Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4876)
All Articles published online
|
Aug 14, 2010 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Campbell NP, Villaflor VM. Neoadjuvant treatment of esophageal cancer. World J Gastroenterol 2010; 16(30): 3793-3803 [PMID: 20698042 DOI: 10.3748/wjg.v16.i30.3793] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v16/i30/3793.htm |
| Number | Citing Articles |
| 1 |
Tristin Abair, Bing-e Xu, Aarati Ranganathan, Tim Quill, Edward Chu, David Cunningham. The Annual Meeting of the American Society of Clinical Oncology. Clinical Colorectal Cancer 2010; 9(4): 195 doi: 10.3816/CCC.2010.n.029
|
| 2 |
Xiao-Mei Zhang, Ming-Zhou Guo. The value of epigenetic markers in esophageal cancer. Frontiers of Medicine in China 2010; 4(4): 378 doi: 10.1007/s11684-010-0230-3
|
| 3 |
Masanobu Nakajima, Hiroyuki Kato, Tatsuya Miyazaki, Takanori Inose, Naritaka Tanaka, Shigemasa Suzuki, Takehiko Yokobori, Makoto Sakai, Akihiko Sano, Keisuke Ieta, Makoto Sohda, Minoru Fukuchi, Hiroyuki Kuwano. An Absolute Standardized Uptake Value Is More Useful than the Decreased Rate of Uptake of FDG-PET to Predict Responses to Neoadjuvant Chemoradiotherapy for Esophageal Cancer. Open Journal of Gastroenterology 2016; 6(11): 373 doi: 10.4236/ojgas.2016.611040
|
| 4 |
Lukas F. Liesenfeld, Peter Sauer, Markus K. Diener, Ulf Hinz, Thomas Schmidt, Beat P. Müller-Stich, Thilo Hackert, Markus W. Büchler, Anja Schaible. Prognostic value of inflammatory markers for detecting anastomotic leakage after esophageal resection. BMC Surgery 2020; 20(1) doi: 10.1186/s12893-020-00995-2
|
| 5 |
Yuhong Zhang, Minqi Zhu, Junxian Mo, Lei Xian. Tumor microenvironment characterization in esophageal cancer identifies prognostic relevant immune cell subtypes and gene signatures. Aging 2021; 13(24): 26118 doi: 10.18632/aging.203800
|
| 6 |
John M. Findlay, Kevin M. Bradley, Lai Mun Wang, James M. Franklin, Eugene J. Teoh, Fergus V. Gleeson, Nicholas D. Maynard, Richard S. Gillies, Mark R. Middleton. Predicting Pathologic Response of Esophageal Cancer to Neoadjuvant Chemotherapy: The Implications of Metabolic Nodal Response for Personalized Therapy. Journal of Nuclear Medicine 2017; 58(2): 266 doi: 10.2967/jnumed.116.176313
|
| 7 |
Carrie Luu, Marisa Amaral, Jason Klapman, Cynthia Harris, Khaldoun Almhanna, Sarah Hoffe, Jessica Frakes, Jose M Pimiento, Jacques P Fontaine. Endoscopic ultrasound staging for early esophageal cancer: Are we denying patients neoadjuvant chemo-radiation?. World Journal of Gastroenterology 2017; 23(46): 8193-8199 doi: 10.3748/wjg.v23.i46.8193
|
| 8 |
Yu Liu, Deyao Xie, Chang Li, Chaoxi Lin, Jun Zhao. Effects of neoadjuvant chemotherapy combined with radiotherapy in patients with advanced esophageal carcinoma. Oncology Letters 2017; 14(3): 2803 doi: 10.3892/ol.2017.6515
|
| 9 |
R. J. L. F. Loffeld, P. E. P. Dekkers. Experience with Oesophageal Cancer: A Ten-Year Single Centre Study Reflecting Daily Practice. ISRN Gastroenterology 2013; 2013: 1 doi: 10.1155/2013/205417
|
| 10 |
GANG LIN, XIAO-JIANG SUN, QIAN-BO HAN, ZHUN WANG, YA-PING XU, JIA-LEI GU, WEI WU, GU ZHANG, JIN-LIN HU, WEN-YONG SUN, WEI-MIN MAO. Epidermal growth factor receptor protein overexpression and gene amplification are associated with aggressive biological behaviors of esophageal squamous cell carcinoma. Oncology Letters 2015; 10(2): 901 doi: 10.3892/ol.2015.3277
|
| 11 |
Lei Wang, Jianfang Feng, Xiaonan Chen, Wei Guo, Yuwen Du, Yuanyuan Wang, Wenqiao Zang, Shijie Zhang, Guoqiang Zhao. Myricetin enhance chemosensitivity of 5-fluorouracil on esophageal carcinoma in vitro and in vivo. Cancer Cell International 2014; 14(1) doi: 10.1186/s12935-014-0071-2
|
| 12 |
Ari Kassardjian, Hanlin L. Wang. SMAD4-Expressing Pancreatic Ductal Adenocarcinomas Have Better Response to Neoadjuvant Therapy and Significantly Lower Lymph Node Metastasis Rates. Pancreas 2020; 49(9): 1153 doi: 10.1097/MPA.0000000000001636
|
| 13 |
Lukas F. Liesenfeld, Thomas Schmidt, Christine Zhang-Hagenlocher, Peter Sauer, Markus K. Diener, Beat P. Müller-Stich, Thilo Hackert, Markus W. Büchler, Anja Schaible. Self-Expanding Metal Stents for Anastomotic Leaks After Upper Gastrointestinal Cancer Surgery. Journal of Surgical Research 2021; 267: 516 doi: 10.1016/j.jss.2021.06.007
|
| 14 |
J.M. Findlay, M.R. Middleton, I. Tomlinson. A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage. Annals of Oncology 2015; 26(4): 624 doi: 10.1093/annonc/mdu449
|
| 15 |
Yan Jia, Yunsheng Yang, Malcolm V Brock, Baoping Cao, Qimin Zhan, Yazhuo Li, Yuanzi Yu, James G Herman, Mingzhou Guo. Methylation of TFPI-2 is an early event of esophageal carcinogenesis. Epigenomics 2012; 4(2): 135 doi: 10.2217/epi.12.11
|
| 16 |
Ali A. Siddiqui, Avik Sarkar, Sara Beltz, Jason Lewis, David Loren, Thomas Kowalski, John Fang, Kristen Hilden, Douglas G. Adler. Placement of fully covered self-expandable metal stents in patients with locally advanced esophageal cancer before neoadjuvant therapy. Gastrointestinal Endoscopy 2012; 76(1): 44 doi: 10.1016/j.gie.2012.02.036
|
| 17 |
Anthony J. Scholer, Abhineet Uppal, Shu‐Ching Chang, Debopriya Ghosh, Mary Garland‐ Kledzik, Juan Santamaria‐Barria, Adam Khader, Ahmed Dehal, Trevan Fischer, Melanie Goldfarb. Inaccurate pretreatment staging can impact survival in early stage esophageal adenocarcinoma. Journal of Surgical Oncology 2020; 122(5): 914 doi: 10.1002/jso.26101
|
| 18 |
Alvin Gogineni, Maresa Caunt, Ailey Crow, Chingwei V. Lee, Germaine Fuh, Nicholas van Bruggen, Weilan Ye, Robby M. Weimer, Fabrizio Mattei. Inhibition of VEGF-C Modulates Distal Lymphatic Remodeling and Secondary Metastasis. PLoS ONE 2013; 8(7): e68755 doi: 10.1371/journal.pone.0068755
|
| 19 |
Sara Ibrahim-Shaikh, Noah Shaikh, Nour Daboul, Esra Alshaikhnassir, Maria Hafez, Monika E. Freiser, Ioannis D. Bassukas. Metastatic Esophageal Adenocarcinoma Presenting as Neck Dermal Metastasis. Case Reports in Dermatological Medicine 2024; 2024: 1 doi: 10.1155/2024/7951391
|
| 20 |
Guobo Peng, Yizhou Zhan, Yanxuan Wu, Chengbing Zeng, Siyan Wang, Longjia Guo, Weitong Liu, Limei Luo, Ruoheng Wang, Kang Huang, Baotian Huang, Jianzhou Chen, Chuangzhen Chen. Radiomics models based on CT at different phases predicting lymph node metastasis of esophageal squamous cell carcinoma (GASTO-1089). Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.988859
|
| 21 |
J. Talvas, G. Garrait, N. Goncalves-Mendes, J. Rouanet, J. Vergnaud-Gauduchon, F. Kwiatkowski, P. Bachmann, C. Bouteloup, J. Bienvenu, M.-P. Vasson. Immunonutrition stimulates immune functions and antioxidant defense capacities of leukocytes in radiochemotherapy-treated head & neck and esophageal cancer patients: A double-blind randomized clinical trial. Clinical Nutrition 2015; 34(5): 810 doi: 10.1016/j.clnu.2014.12.002
|
| 22 |
Feng Wang, Lan Zhang, Yue Xu, Yilin Xie, Shenglei Li. Comprehensive Analysis and Identification of Key Driver Genes for Distinguishing Between Esophageal Adenocarcinoma and Squamous Cell Carcinoma. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.676156
|
| 23 |
Yan-Han Xu, Peng Lu, Ming-Cheng Gao, Rui Wang, Yang-Yang Li, Rong-Qi Guo, Wei-Song Zhang, Jian-Xiang Song. Nomogram based on multimodal magnetic resonance combined with B7-H3mRNA for preoperative lymph node prediction in esophagus cancer. World Journal of Clinical Oncology 2024; 15(3): 419-433 doi: 10.5306/wjco.v15.i3.419
|
| 24 |
Xining Zhang, Kang Qi, Weiming Huang, Jingwei Liu, Gang Lin, Jian Li. Left versus right approach for middle and lower esophageal squamous cell carcinoma: A propensity score-matched study. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.858660
|
| 25 |
Michele Fiore, Lucio Trodella, Sergio Valeri, Domenico Borzomati, Barnaba Floreno, Edy Ippolito, Pasquale Trecca, Luca Eolo Trodella, Rolando Maria D’Angelillo, Sara Ramella, Roberto Coppola. Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancer. Radiation Oncology 2015; 10(1) doi: 10.1186/s13014-015-0564-8
|
| 26 |
Keduovinuo K. Keditsu, Sabita Jiwnani, George Karimundackal, C. S. Pramesh. Multimodality Management of Esophageal Cancer. Indian Journal of Surgical Oncology 2013; 4(2): 96 doi: 10.1007/s13193-013-0216-0
|
| 27 |
Yun Yang, Ziyin Tian, Yanke Ding, Xiaojing Li, Ziheng Zhang, Liu Yang, Fangyu Zhao, Feng Ren, Rui Guo. EGFR-Targeted Immunotoxin Exerts Antitumor Effects on Esophageal Cancers by Increasing ROS Accumulation and Inducing Apoptosis via Inhibition of the Nrf2-Keap1 Pathway. Journal of Immunology Research 2018; 2018: 1 doi: 10.1155/2018/1090287
|
| 28 |
Xiao-Fang Guo, Xiao-Fei Zhu, Wan-Cai Yang, Sheng-Hua Zhang, Yong-Su Zhen, Karl X. Chai. An EGFR/HER2-Bispecific and Enediyne-Energized Fusion Protein Shows High Efficacy against Esophageal Cancer. PLoS ONE 2014; 9(3): e92986 doi: 10.1371/journal.pone.0092986
|
| 29 |
Catarina Macedo-Silva, Vera Miranda-Gonçalves, Rui Henrique, Carmen Jerónimo, Isabel Bravo. The Critical Role of Hypoxic Microenvironment and Epigenetic Deregulation in Esophageal Cancer Radioresistance. Genes 2019; 10(11): 927 doi: 10.3390/genes10110927
|
| 30 |
Prashant Sukharamwala, Daniel Hennessey, Thomas Wood, Shelly Singh, Carrie Ryan, Alexander Rosemurgy. Molecular profiles in foregut oncology. Cancer Genetics 2016; 209(12): 537 doi: 10.1016/j.cancergen.2016.09.008
|
| 31 |
John M Findlay, Richard S Gillies, James M Franklin, Eugene J Teoh, Greg E Jones, Sara di Carlo, Fergus V Gleeson, Nicholas D Maynard, Kevin M Bradley, Mark R Middleton. Restaging oesophageal cancer after neoadjuvant therapy with 18F-FDG PET-CT: identifying interval metastases and predicting incurable disease at surgery. European Radiology 2016; 26(10): 3519 doi: 10.1007/s00330-016-4227-4
|
| 32 |
M. Mura Assifi, Xuyang Lu, Guido Eibl, Howard A. Reber, Gang Li, O. Joe Hines. Neoadjuvant therapy in pancreatic adenocarcinoma: A meta-analysis of phase II trials. Surgery 2011; 150(3): 466 doi: 10.1016/j.surg.2011.07.006
|
| 33 |
Tomas DaVee, Jaffer A Ajani, Jeffrey H Lee. Is endoscopic ultrasound examination necessary in the management of esophageal cancer?. World Journal of Gastroenterology 2017; 23(5): 751-762 doi: 10.3748/wjg.v23.i5.751
|
| 34 |
Catarina Macedo-Silva, Vera Miranda-Gonçalves, Ana Lameirinhas, Joana Lencart, Alexandre Pereira, João Lobo, Rita Guimarães, Ana Teresa Martins, Rui Henrique, Isabel Bravo, Carmen Jerónimo. JmjC-KDMs KDM3A and KDM6B modulate radioresistance under hypoxic conditions in esophageal squamous cell carcinoma. Cell Death & Disease 2020; 11(12) doi: 10.1038/s41419-020-03279-y
|
| 35 |
Ming Wang, Liang Wang, Xiang He, Jinhua Zhang, Zhongcheng Zhu, Mingyun Zhang, Xingde Li. lncRNA CCAT2 promotes radiotherapy resistance for human esophageal carcinoma cells via the miR‑145/p70S6K1 and p53 pathway. International Journal of Oncology 2019; doi: 10.3892/ijo.2019.4929
|
| 36 |
A. Herskovic, W. Russell, M. Liptay, M.J. Fidler, M. Al-Sarraf. Esophageal carcinoma advances in treatment results for locally advanced disease: review. Annals of Oncology 2012; 23(5): 1095 doi: 10.1093/annonc/mdr433
|
| 37 |
Juliana Yang, Ali A. Siddiqui, Thomas E. Kowalski, David E. Loren, Ammara Khalid, Ayesha Soomro, Syed M. Mazhar, Julian Rosé, Laura Isby, Michel Kahaleh, Ankush Kalra, Alex M. Sarkisian, Nikhil A. Kumta, Jose Nieto, Reem Z. Sharaiha. Esophageal stent fixation with endoscopic suturing device improves clinical outcomes and reduces complications in patients with locally advanced esophageal cancer prior to neoadjuvant therapy: a large multicenter experience. Surgical Endoscopy 2017; 31(3): 1414 doi: 10.1007/s00464-016-5131-3
|
| 38 |
Yun Yang, Ziyin Tian, Xinghua Zhao, Ya Li, Shuyan Duan. A novel antitumor dithiocarbamate compound inhibits the EGFR/AKT signaling pathway and induces apoptosis in esophageal cancer cells. Oncology Letters 2020; 20(1): 877 doi: 10.3892/ol.2020.11638
|
| 39 |
Wenqing Cao, Jeffrey H Peters, Dylan Nieman, Meenal Sharma, Thomas Watson, JiangZhou Yu. Macrophage subtype predicts lymph node metastasis in oesophageal adenocarcinoma and promotes cancer cell invasion in vitro. British Journal of Cancer 2015; 113(5): 738 doi: 10.1038/bjc.2015.292
|
| 40 |
Takahiro Tsuchikawa, Masaki Miyamoto MD, Yoshiyuki Yamamura, Toshiaki Shichinohe, Satoshi Hirano, Satoshi Kondo. The Immunological Impact of Neoadjuvant Chemotherapy on the Tumor Microenvironment of Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology 2012; 19(5): 1713 doi: 10.1245/s10434-011-1906-x
|
| 41 |
Bassan J. Allan, Felipe Pedroso, Elisabeth R. Gennis, Alan S. Livingstone, Alberto Montero, Brian Lally, Bach Ardalan, Leonidas G. Koniaris, Naveenraj L. Solomon, Dido Franceschi. Influence of Treatment Modality in Outcomes for Different Stages of Resectable Esophageal Adenocarcinomas. Annals of Surgical Oncology 2013; 20(5): 1660 doi: 10.1245/s10434-012-2766-8
|
| 42 |
Ebru Cilbir, Suayib Yalcin. Textbook of Gastrointestinal Oncology. 2019; : 55 doi: 10.1007/978-3-030-18890-0_4
|
| 43 |
Kim Vaiphei, Saroj Kant Sinha, Rakesh Kochhar. Comparative Analysis of Oct4 in Different Histological Subtypes of Esophageal Squamous Cell Carcinomas in Different Clinical Conditions. Asian Pacific Journal of Cancer Prevention 2014; 15(8): 3519 doi: 10.7314/APJCP.2014.15.8.3519
|
| 44 |
J M Findlay, K M Bradley, L M Wang, J M Franklin, E J Teoh, F V Gleeson, N D Maynard, R S Gillies, M R Middleton. Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancer. British Journal of Surgery 2017; 104(4): 408 doi: 10.1002/bjs.10435
|
| 45 |
Yu Fang, Dianchun Fang, Jianguo Hu. MicroRNA and its roles in esophageal cancer. Medical Science Monitor 2012; 18(3): RA22 doi: 10.12659/MSM.882509
|
| 46 |
Maki Yamamoto, Jill M. Weber, Richard C. Karl, Kenneth L. Meredith. Minimally Invasive Surgery for Esophageal Cancer: Review of the Literature and Institutional Experience. Cancer Control 2013; 20(2): 130 doi: 10.1177/107327481302000206
|
| 47 |
Yajuan Lv, Meijuan Song, Xiufang Tian, Xinshuang Yv, Ning Liang, Jiandong Zhang. Impact of radiotherapy on circulating lymphocyte subsets in patients with esophageal cancer. Medicine 2020; 99(36): e20993 doi: 10.1097/MD.0000000000020993
|
| 48 |
Thomas J. Hardacker, DuyKhanh Ceppa, Ikenna Okereke, Karen M. Rieger, Shadia I. Jalal, Julia K. LeBlanc, John M. DeWitt, Kenneth A. Kesler, Thomas J. Birdas. Treatment of Clinical T2N0M0 Esophageal Cancer. Annals of Surgical Oncology 2014; 21(12): 3739 doi: 10.1245/s10434-014-3929-6
|
| 49 |
Po-Kuei Hsu, Bing-Yen Wang, Chien-Sheng Huang, Yu-Chung Wu, Wen-Hu Hsu. Prognostic Factors for Post-recurrence Survival in Esophageal Squamous Cell Carcinoma Patients with Recurrence after Resection. Journal of Gastrointestinal Surgery 2011; 15(4): 558 doi: 10.1007/s11605-011-1458-1
|
| 50 |
David Bunting, Richard Berrisford, Tim Wheatley, Lee Humphreys, Arun Ariyarathenam, Grant Sanders. Prospective cohort study of neoadjuvant therapy toxicity in the treatment of oesophageal adenocarcinoma. International Journal of Surgery 2018; 52: 126 doi: 10.1016/j.ijsu.2018.02.023
|